The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus
NCT01905202
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Barrett's Esophagus
Interventions
DRUG:
Secretrol
Sponsor
Effexus Pharmaceutical